Demis Hassabis raises $2.1 billion for Isomorphic Labs to accelerate AI drug discovery
Demis Hassabis talks to Fortune about how a $2.1 billion Series B will ‘turbocharge’ Isomorphic.
Read the full articleYou might also wanna read
Google DeepMind CEO claims goal of "solving all disease" through AI drug discovery
In this special Optimizer issue, we contextualize a bold claim by Google DeepMind CEO Demis Hassabis during the 2026 I/O keynote.
The Verge·1mo ago
Demis Hassabis emerges as key figure in Musk v. Altman trial testimony
About a week into the Musk v. Altman trial, one thing is clear: DeepMind CEO Demis Hassabis was constantly on Elon Musk’s mind, as well as o
The Verge·2mo agoDemis Hassabis has a plan to harness AI safely
The Google Deepmind co-founder sets out his vision in an exclusive interview
DeepMind CEO Demis Hassabis urges U.S. to create global AI watchdog with power to slow dangerous models
We could be standing "in the foothills of the singularity," the DeepMind CEO writes in a new manifesto.
axios.com·2d agoAlphaFold Won the Nobel Prize for Predicting Proteins. Now the Same Team Is Designing the Drugs.
Isomorphic Labs raised $2.1B in May 2026 to push its first AI-designed drugs into clinical trials. The DeepMind spinout's IsoDDE engine does
DeepMind’s Demis Hassabis Advocates for AI Standards Body
In a bold move for the tech world, Demis Hassabis, the head honcho at DeepMind, is calling for the creation of an independent body to [...]
Comments
Sign in to join the conversation.
No comments yet. Be the first.